SARAYA BRAUN: Open Payments
NPI 1306531413 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 74 payments from 13 companies in 2025. Trend: 2023 $332 · 2024 $913 · 2025 $1,170
Food & beverage: $1,158Education: $12
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 25 | $294 |
| Vanda Pharmaceuticals Inc. | 10 | $227 |
| ABBVIE INC. | 18 | $190 |
| Corium, LLC | 6 | $129 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Supernus Pharmaceuticals, Inc. | 3 | $58 |
| Lilly USA, LLC | 2 | $54 |
| Tris Pharma Inc | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $23 |
Products named: SPRAVATO, FANAPT, VRAYLAR, Azstarys, Auvelity, Qelbree, MOUNJARO, Dyanavel XR.
Industry payments across MS — which companies pay providers there.
